References
- American Diabetes Association (2003). Management of dyslipidemia in adults with diabetes. Diabetes Care 26:S83-S86 https://doi.org/10.2337/diacare.26.2007.S83
- A.O.A.C. (1995). Official methods of analysis. 14th ed. Association of official analytical chemists, Washington DC. USA
- Azuma K, Toyofuku Y, Iesaki T, Otsuka A, Tanaka A, Mita T, Hirose T, Tanaka Y, Daida H, Kawamori R & Watada H (2006). Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 345:688-693 https://doi.org/10.1016/j.bbrc.2006.04.090
- Balflour JA & McTavish D (1993). Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 46:1025-1054 https://doi.org/10.2165/00003495-199346060-00007
- Centers for Disease Control and Prevention (1999). Diabetes Surveillance Report, Atlanta, GA: US Department of Health and Human Services
- Chung BS & Shin MG (1990). Dictionary of Korean Folk Medicine, p.813. Young Lim Sa, Seoul. Republic of Korea
- Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger P & McGill JB (1995). Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. Diabetes Care 18:817-824 https://doi.org/10.2337/diacare.18.6.817
- Dahlqvist A (1984). Assay of intestinal disaccharidases. Scand J Clin Lab Invest 44:169-172 https://doi.org/10.3109/00365518409161400
- Fujita H & Yamagami T (2001). Fermented soybean-derived touchiextract with anti-diabetic effect via alpha-glucosidase inhibitory action in a long-term administration study with KKAy mice. Life Sci 70:219-227 https://doi.org/10.1016/S0024-3205(01)01381-9
-
Fujita H, Yamagami T & Ohshima K (2001). Fermented soybeanderived touchi extract with anti-glycaemic effect via
${\alpha}$ -glucosidase inhibitory action in rats and humans. J Nutr 131:1211-1213 -
Fujita H, Yamagami T & Ohshima K (2003). Long-term ingestion of touchi-extract,
${\alpha}$ -glucosidase inhibitor, by borderline and mild type-2 diabetic subjects is safe and significantly reduces blood glucose levels. Nutr Res 23:713-722 https://doi.org/10.1016/S0271-5317(03)00028-9 - Hanefeld M (1988). The Role of acarbose in the treatment of non-insulin-dependent diabetes mellitus. J Diabetes Complications 12:228-237 https://doi.org/10.1016/S1056-8727(97)00123-2
- Holman RR, Cull CA & Turner RC (1999). A randomized doubleblind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44) Diabetes Care 22:960-964 https://doi.org/10.2337/diacare.22.6.960
- Joo HJ, Kang MJ, Seo TJ, Kim HA, Yoo SJ, Lee SK, Lim HJ, Byun BH & Kim JI (2006). The hypoglycemic effect of S. chinensis Baill in animal models of diabetes mellitus. Food Science and Biotechnology 15:413-417
- Juretic D, Bernik S, Cop L, Hadzila M, Petlevski R & Lukac-Bajalo J (2003). Short-term effect of acarbose on specific intestinal disaccharidase activities and hyperglycaemia in CBA diabetic mice. J Anim Physiol Anim Nutr (Berl) 87:263-268 https://doi.org/10.1046/j.1439-0396.2003.00435.x
- King H, Aubert RE & Herman WH (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431 https://doi.org/10.2337/diacare.21.9.1414
- Kwon CS, Son KH & Kim JS (2004). Effect of Lonicera japonica flower on body weight gain and glucose tolerance in rodents. Food Science and Biotechnology 13:768-771
- Kwon EH, Jang HS, Kim SW, Choi SW, Rhee SJ & Cho SH (2007). Effects of mulberry juice and cake powders on blood glucose and lipid lowering and erythrocyte antioxidative enzyme activities in sterptozotocin-induced diabetic rats. Korean Journal of Nutrition 40:199-210
-
Lebovitz HE (1998).
$ \alpha$ -Glucosidase inhibitors as agents in the treatment of diabetes. Diabetes Reviews 6:132-145 - Lowry OH, Rosenbrough NJ, Farr AL & Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
-
Matsui T, Yoshimoto C, Osajima K, Oki T, Osajima Y, Oki T & Osajima Y (1996). In vitro survey of
${\alpha}$ -glucosidase inhibitory food components. Biosci Biotechnol Biochem 60:2019-2022 https://doi.org/10.1271/bbb.60.2019 - Mughal MA, Memon MY, Zardari MK, Tanwani RK & Ali M (2000). Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes. J Pak Med Assoc 50:152-156
- Murali B, Upadhyaya UM & Goyal RK (2002). Effect of chronic treatment with Enicostemma littorale in non-insulin-dependent diabetic (NIDDM) rats. J Ethnopharmacol 81:199-204 https://doi.org/10.1016/S0378-8741(02)00077-6
- Qualmann C, Nauck MA, Holst JJ, Orskov C & Creutzfeldt W (1995). Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Scand J Gastroenterol 30:892-896 https://doi.org/10.3109/00365529509101597
-
Saito N, Sakai H, Sekihara H & Yajima Y (1998). Effect of an
$ \alpha$ -glucosidase inhibitor (voglibose), in combination with sulphonilureas, on glycaemic control in type 2 diabetes subjects. J Int Med Res 26:219-232 https://doi.org/10.1177/030006059802600501 - Seifarth C, Bergmann J, Holst JJ, Ritzel R, Schmiegel W & Nauck MA (1998). Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in type 2 diabetic patients. Diabet Med 15:485-491 https://doi.org/10.1002/(SICI)1096-9136(199806)15:6<485::AID-DIA610>3.0.CO;2-Y
- Sels JP, Huijberts MS & Wolffenbuttel BH (1999). Miglitol, a new alpha-glucosidase inhibitor. Expert Opin Pharmacother 1:149-156 https://doi.org/10.1517/14656566.1.1.149
- Stand E, Baumgartl HJ, Fuchtenbusch M & Stemplinger J (1999). Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy. Diabetes Obes Metab 1:215-220 https://doi.org/10.1046/j.1463-1326.1999.00021.x
- The Diabetes Control and Complications Trial (DCCT) Research Group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in the diabetes control in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986 https://doi.org/10.1056/NEJM199309303291401
- Toeller M (1994). Alpha-glucosidase inhibitors in diabetes: efficacy in NIDDM subjects. Eur J Clin Invest. 24:31-35 https://doi.org/10.1111/j.1365-2362.1994.tb02253.x
- UK Prospective Diabetes Study (UKPDS) Group (1998). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ 317:703-713
-
Watanabe J, Kawabata J, Kurihara H & Niki R (1997). Isolation and identification of
$ \alpha$ -glucosidase inhibitors from Tochu-cha (Encommia ulmoides). Biosci Biotechnol Biochem 61:177-178 https://doi.org/10.1271/bbb.61.177 - Yamashita K, Sugawara S & Sakairi I (1984). Effects of an alpha-glucosidase inhibitor, acarbose, on blood glucose and serum lipids in streptozotocin-induced diabetic rats. Horm Metab Res 16:179-182 https://doi.org/10.1055/s-2007-1014737
- Yoo SK, Kim MJ, Kim JW & Rhee SJ (2002). Effects of YK-209 mulberry leasves diasaccharidase activities of small intestine and blood glucose-lowering in sterptozotocin-induced diabetic rats. Journal of the Korean Society Food Science and Nutrition 31:1071-1077 https://doi.org/10.3746/jkfn.2002.31.6.1071
- Zavaroni I & Reaven GM (1981). Inhibition of carbohydrate-induced hypertriglyceridemia by a disaccharidase inhibitor. Metabolism 30:417-420 https://doi.org/10.1016/0026-0495(81)90125-6